Returning integrated genomic risk and clinical recommendations: The eMERGE study.
Jodell E Linder1, Aimee Allworth2, Harris T Bland3
1Vanderbilt Institute for Clinical and Translational Research, Vanderbilt University Medical Center, Nashville, TN.
Summary
Integrated genetic risk assessment reports, combining clinical, monogenic, and polygenic risks, can inform preventive care for individuals at high genetic risk.
Area of Science:
- Genomics
- Preventive Medicine
- Clinical Risk Assessment
Background:
- Assessing complex disease risk requires integrating clinical factors, family history, and genetic predispositions (monogenic and polygenic).
- Communicating genetic risk information to individuals and healthcare providers can guide preventive strategies and prophylactic treatments.
Purpose of the Study:
- To develop and evaluate a novel genome-informed risk assessment (GIRA) report for integrated genetic risk assessment.
- To assess the uptake of care recommendations following the return of GIRA results.
Main Methods:
- The electronic MEdical Records and GEnomics (eMERGE) network is conducting a prospective cohort study of 25,000 diverse participants across 10 sites.
- Methods were developed to return cross-ancestry polygenic risk scores, monogenic risks, family history, and clinical risk assessments via a GIRA report.
Main Results:
- The GIRA report includes summary care recommendations for 11 conditions, educational materials, and clinical laboratory findings.
- High-risk GIRA reports provide care and lifestyle guidelines for individuals and providers.
- Infrastructure and workflows were established for content integration and presentation.
Conclusions:
- A novel report communicating integrated genetic risk factors (monogenic, polygenic, family history) demonstrates the value of genetic risk assessment in routine healthcare.
- This approach has the potential to improve preventive care and patient outcomes.
More Related Videos
Related Concept Videos
Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches
156
Biopharmaceutical studies constitute a vital field aiming to enhance drug delivery methods and refine therapeutic approaches, drawing upon diverse interdisciplinary knowledge. In research methodologies, the choice between controlled and non-controlled studies significantly influences the study's reliability and accuracy.
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...
156
Relative Risk
273
Relative risk (RR) is a statistical measure commonly used in epidemiology to compare the likelihood of a particular event occurring between two groups. This metric is important for evaluating the relationship between exposure to a specific risk factor and the probability of a particular outcome. It plays a crucial role in medical research, public health studies, and risk assessment. Relative risk quantifies how much more (or less) likely an event is to occur in an exposed group compared to an...
273
Clinical Trials: Overview
3.1K
Clinical development focuses on how the drug will interact with the human body and encompasses four key phases of clinical trials, each serving a specific purpose in assessing the safety and effectiveness of new drugs. These phases overlap and build upon one another. Phase I involves a small group of healthy volunteers (typically 20-80 individuals) or, in cases where significant toxicity is expected, patients with the targeted disease, such as cancer or AIDS. The volunteers are tested for...
3.1K
Cancer-Critical Genes II: Tumor Suppressor Genes
7.6K
Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
7.6K
Clinical Trials
6.9K
Clinical trials are prospective experimental studies conducted on humans to determine the safety and efficacy of treatments, drugs, diet methods, and medical devices. Using statistics in clinical trials enables researchers to derive reasonable and accurate conclusions from the collected data, allowing them to make wise decisions in uncertain situations. In medical research, statistical methods are crucial for preventing errors and bias.
There are four phases in a clinical trial. A phase one...
There are four phases in a clinical trial. A phase one...
6.9K
Cancer Survival Analysis
411
Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...
411


